Home / Biotechnology / Immunohistochemistry Market By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Drug Testing) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

Immunohistochemistry Market By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Drug Testing) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

Published: Sep 2017 | Report Code: 58664-09-17

Global Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents and Kits) by Applications (Diagnostics and Drug Testing) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma. A strong limitation of immunohistochemistry is the number of parameters that can be detected, and the capacity of multiplexing immunohistochemistry is very limited.

For the purpose of this study, the various products studied includes antibodies, equipment, reagents and kits. The applications are classified as diagnostics and drug testing. Antibodies are further classified as (primary antibodies, secondary antibodies). Equipment’s are categorized as (slide staining systems, tissue microarrays, tissue processing system, slide scanners and others). Reagents are further sub segmented as (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes and diluents). Diagnostics are further segmented as (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetic mellitus, and nephrological diseases). Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global immunohistochemistry market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global immunohistochemistry market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global immunohistochemistry market. The key players profiled in this report are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., and Thermo Fisher Scientific, Inc.

Immunohistochemistry Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Immunohistochemistry Market Portraiture
2.1.1. Global Immunohistochemistry Market, by Product, 2016
2.1.2. Global Immunohistochemistry Market, by Application, 2016
2.1.3. Global Immunohistochemistry Market, by Geography, 2016

Chapter 3. Global Immunohistochemistry Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Immunohistochemistry Market, by Product
4.3. Antibodies
4.3.1. Primary Antibodies
4.3.2. Secondary Antibodies
4.4. Equipment
4.4.1. Slide Staining Systems
4.4.2. Tissue Microarrays
4.4.3. Tissue Processing Systems
4.4.4. Slide Scanners
4.4.5. Others
4.5. Reagents
4.5.1. Histological Stains
4.5.2. Blocking Sera and Reagents
4.5.3. Chromogenic Substrates
4.5.4. Fixation Reagents
4.5.5. Stabilizers
4.5.6. Organic Solvents
4.5.7. Proteolytic Enzymes
4.5.8. Diluents
4.6. Kits

Chapter 5. Global Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Immunohistochemistry Market, by Application
5.3. Diagnostics
5.3.1. Cancer
5.3.2. Infectious Diseases
5.3.3. Cardiovascular Diseases
5.3.4. Autoimmune Diseases
5.3.5. Diabetes Mellitus
5.3.6. Nephrological Diseases
5.4. Drug Testing

Chapter 6. Global Immunohistochemistry Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Immunohistochemistry Market Analysis, 2015 – 2025
6.2.1. North America Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Immunohistochemistry Market Analysis, 2015 – 2025
6.3.1. Europe Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Rest of Europe
6.4. Asia Pacific Immunohistochemistry Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia PacificImmunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Immunohistochemistry Market Analysis, 2015 – 2025
6.5.1. Latin America Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Immunohistochemistry Market Analysis, 2015 – 2025
6.6.1. MEA Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. MEA Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. MEA Immunohistochemistry Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abcam plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Agilent Technologies, Inc.
7.3. Bio-Rad Laboratories, Inc.
7.4. BioSB
7.5. Cell Signaling Technology, Inc.
7.6. Danaher Corporation
7.7. F.Hoffman La-Roche Ltd
7.8. Merck Millipore Corporation
7.9. Perkin Elmer, Inc.
7.10. Thermo Fisher Scientific, Inc.
7.11. Other Notable Players

List Of Table :

TABLE 1 Global Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Immunohistochemistry Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 5 North America Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 North America Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Immunohistochemistry Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Immunohistochemistry Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Immunohistochemistry Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Immunohistochemistry Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 19 Abcam Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 BioSB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Cell Signaling Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 F.Hoffman La-Roche Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Perkin Elmer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage) 

List Of Figure :

FIG. 1 Immunohistochemistry: Market Segmentation
FIG. 2 Global Immunohistochemistry Market Share, by Product, 2016 (Value %)
FIG. 3 Global Immunohistochemistry Market Share, by Application, 2016 (Value %)
FIG. 4 Global Immunohistochemistry Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global ImmunohistochemistryAntibodies Market 2015 – 2025 (US$ Mn)
FIG. 8 Global Immunohistochemistry Equipment Market2015 – 2025 (US$ Mn)
FIG. 9 Global ImmunohistochemistryReagents Market 2015 – 2025 (US$ Mn)
FIG. 10 Global Immunohistochemistry Kits Market 2015 – 2025 (US$ Mn)
FIG. 11 Global Immunohistochemistry Diagnostics Market 2015 – 2025 (US$ Mn)
FIG. 12 Global Immunohistochemistry Drug Testing Market 2015 – 2025 (US$ Mn)
FIG. 13 U.S. Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 14 Canada Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 15 U.K. Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 16 Germany Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 17 France Immunohistochemistry Market, 2015-2025 (US$ Mn)
FIG. 18 Rest of Europe Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Asia Pacific Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Latin America Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Immunohistochemistry Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest of Middle East and Africa Immunohistochemistry Market, 2015 – 2025 (US$ Mn)

Based on product types, the global immunohistochemistry market is categorized into

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Immunohistochemistry Market

The immunohistochemistry market is driven by factors such as rising prevalence of cancer, aging population suffering with chronic diseases and urgent requirement for novel drug discovery in cases such as multiple drug resistance bacterial infection. In addition, increasing number of diagnostic centers and increasing physician awareness regarding disease etiology will propel the deep market penetration for immunohistochemistry. In 2016, antibodies segment held the largest market share chiefly due to factors such as technological advancement in the production and development of antigen specific antibodies finding immense requirement in diagnosis and stem cell population determination etc., increasing demand for personalized medication and the recent technological advancement in biologicals for the treatment of chronic diseases.

Reagents will be the fastest growing segment throughout the forecast period 2017-2025 majorly due to factors such as rising prevalence of chronic diseases, steadily increasing diagnostic centers and public private partnership to combat life threatening diseases by setting research and development centers. The major players in immunohistochemistry market are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., Thermo Fisher Scientific, Inc. and other notable players.

Based on applications, the global immunohistochemistry market is categorized into

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Immunohistochemistry Market

The crucial application of immunohistochemistry is the use of antibodies being employed to study the tissue distribution of an antigen. The eukaryotic cells use histone proteins to store the DNA in the form of chromatin material, in order to understand the genetic relations to the chronic diseases the antibodies can be employed to target histones. Immunohistochemistry is a comprehensive technique which is employed for morphological characterization of tumors and other tissue malignancies. In 2016, diagnostics segment dominated the market mainly due to factors such as rising prevalence of chronic diseases requiring immediate medical intervention and increasing public health awareness resulting into the rising number of diagnostic centers. Additionally the technological advancement in the diagnostics techniques that use antibodies to identify podocalyxin (PODXL) a trans-membrane protein involved in cell-cell interaction expressed in several cancers such as breast, prostate, testicular, colorectal and urothelial cancer. The drug testing segment is anticipated to register faster growth throughout the forecast period 2017-2025, majorly due to rising incidence of drug related adverse events and study the microbe metabolism due to increasing incidence of multiple drug resistance bacterial infection.

For the purpose of this study, the global immunohistochemistry market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Immunohistochemistry Market

North America was observed to be the largest market for immunohistochemistry in the base year 2016. According to the Center for Disease Control and Prevention, in 2012, about half of the American population suffered with one or more chronic health conditions. The dominance of North America is mainly attributed to the presence of key drivers such as rising prevalence of chronic disease, matured biotechnology market, increasing commercialization of the immunohistochemistry products and developed research and healthcare institutions. The market growth in Europe is mainly attributed to the rising prevalence of chronic diseases, as per the OECD/European Commission report 2016 approximately 550,000 premature deaths were reported across European Union. This factor boosts the demand for antibodies for the identification and screening of biomarkers related to chronic diseases and technological advancement in the tissue processing systems and chromogenic substrates employed for tissue sampling.

Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are the increasing number of geriatric population suffering with chronic health complications, competitive market due to presence of existing major players and evolving biopharmaceutical manufacturers producing immunohistochemistry reagents and equipment in these regions, and supportive regulatory environment for immunohistochemistry products. Moreover, factors such as developing health infrastructure, expansion of research centers by pharmaceutical giants to propel deep market penetration in the untapped market of remote areas with unmet medical needs are going to fuel the rapid growth of immunohistochemistry market in Latin America, and Middle East and Africa region in the near future.   

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients